Scientific Programme

Transcription

1 Scientific Programme Friday, 18 January Welcome M.Brausi, Modena (IT) M. Babjuk, Prague (CZ) Opening address History and impact of ESOU in onco urology M. Brausi, Modena (IT) Prostate cancer I: Prevention, diagnosis and active surveillance Chairs : M Brausi, Modena (IT) M. Wirth, Dresden (DE) Prostate cancer prevention: An update S. Brookman May, Munich (DE) Why genetic tests are not there yet J. Moul, Durham (US) Debate: mp MRI should be used routinely in patients with an elevated PSA (short introductory case how to digest the PRECISION study introduced by chair) YES always C. Moore, London (GB) NO only in selected cases N. Mottet, Saint Etienne (FR) Discussion Definition and interpretation of PI RADS 3 on mp MRI: Counselling patients J. Barentsz, Njimegen (NL) Radiologist J. Radtke, Heidelberg (DE) Urologist Discussion Prostate cancer II Chairs: B. Djavan, Vienna (AT) N. Mottet, Saint Etienne (FR) Risk stratification for active surveillance N. Mottet, Saint Etienne (FR)

2 Discussion The role of mpmr in active surveillance : Case presentation and discussion A. Masson Lecomte, Paris (FR) J. Barentsz, Nijmegen (NL) Break Treatment of GS 7 (3+4) in an MDT scenario : Case presentation and debate Active surveillance M. Roobol, Rotterdam (NL) Focal therapy C. Orczyk, London (GB) Surgery H. Van der Poel, Amsterdam (NL) Hypofractionation RT A. Bossi, Villejuif (FR) Discussion What is high quality local treatment in high risk localised prostate cancer? Surgery Radiotherapy P. Nguyen, Boston (US) Discussion Lunch Renal cancer I: Localised: Diagnosis Chairs: H. Van Poppel, Leuven (BE) A. Volpe, Novara (IT) Diagnosis and treatment of cystic renal masses Classification and role of cross sectional imaging (CT/MRI) J. Walz, Marseille (FR) Role of contrast enhanced ultrasound J. Rübenthaler, Munich (DE) Case presentation and debate Cystic renal tumors: What is the best surgical approach for partial nephrectomy? Chair: A. Volpe, Novara (IT) Open (video) H. Van Poppel, Leuven (BE)

3 Laparoscopy (video) P. Chlosta, Cracow (PL) Robotic (video) R. Nair, London (GB) Discussion Debate T2 renal tumors: what is the best surgical treatment? Radical nephrectomy P. Mulders, Nijmegen (NL) Partial nephrectomy K. Bensalah, Rennes (FR) Discussion Panel discussion of clinical cases: Localized RCC Moderators: A. Alcaraz, Barcelona (ES) M. Sedelaar, Nijmegen (NL) Panel: R. Nair, London (GB) K. Bensalah, Rennes (FR) A. Mottrie, Aalst (BE) Intraperitoneal vs extraperitoneal robotics/lap partial nephrectomy (Videos) Intraperitoneal PN when and how? A. Mottrie, Aalst (BE) The extraperitoneal approach when and how? F. Porpiglia, Turin (IT) Discussion Break Urothelial and bladder cancer I: Diagnosis and staging Chairs: M. Colombel, Lyon (FR) G. Thalmann, Berne (CH) MRI for bladder cancer staging V. Panebianco, Rome (IT) Is en bloc TUR the best staging tool? B. Malavaud, Toulouse (FR)

4 Confocal laser endomicroscopy (Cellvizio) for the diagnosis of Cis and Dysplasia M. Brausi, Modena (IT) Discussion Epigenetics in NMIBC J.A. Witjes, Nijmegen (NL) Discussion Clinical case presentation on NMIBC Moderators: M. Babjuk, Prague (CZ) J. Palou, Barcelona (ES) Panel: A. Brisuda, Prague (CZ) M. Colombel, Lyon (FR) B. Malavaud, Toulouse (FR) J. Witjes, Nijmegen (NL) A. Xylinas, Paris (FR)

5 Saturday, 19 January Prostate Cancer III: Locally advanced disease Chairs: Reliability of PET CT in primary staging Discussion Treatment of positive pelvic lymph nodes: clinical case in MDT Surgery Radio hormonal therapy T. Wiegel, Ulm (DE) Systemic treatments M. De Santis, Berlin (DE) Genomics G. Kristiansen, Bonn (DE) Discussion How to deal with nightmare complications of surgery and radiotherapy Fistulae G. Bislenghi, Leuven (BE) Radiation cystitis M. Colombel, Lyon (FR) Recurrent strictures R. Djinovic, Belgrade (RS) Discussion Case discussion: Predictors of local regional recurrence Chair : J. Moul, Durham (US) Discussion Break Panel N. Fossati, Milan (IT) D. Pfister, Cologne (DE)

6 Penile and testis cancer Chairs: S. Minhas, London (GB) N. Nicolai, Milan (IT) Minimally invasive inguinal lymphadenectomy J. Gaya Sopena, Barcelona (ES) MDT case discussion: Multi modal treatment bulky disease Panel: G. de Meerleer, Ghent (BE) M. de Santis, Berlin (DE) N. Nicolai, Milan (IT) Molecular markers for staging and monitoring testis cancer A. Radtke, Bremen (DE) Discussion The role of RPLND in tumour marker negative stage 2 A B: Pro/con Pro: P. Albers, Dusseldorf (DE) Con: T. Tandstad, Trondheim (NO) Challenging the dogma in surgical treatment of testis cancer Lunch Urothelial cancer II Chairs: M. Babjuk, Prague (CZ) J. Palou, Barcelona (ES) Genetics in urothelial cancer S. Lerner, Houston (US) Panel discussion: Challenging case : Low volume MIB Panel: J. Bellmunt, Barcelona (ES) G. Thalmann, Berne (CH) P. Nguyen, Boston (US) S. Lerner, Houston (US) Optimising functional outcomes in radical cystectomy Prostate sparing approaches R. Sanchez Salas, Paris (FR) Robotic nerve sparing RC J. Palou, Barcelona (ES) Open nerve sparing RC A. Stenzl Tubingen (DE) Discussion

7 Conservative management of upper tract urinary cancer A. Breda, Barcelona (ES) Discussion POUT Trial Final result R. Jones, Glasgow (GB) Discussion New perspectives in UUT TCC Treatment M. Roupret, Paris (FR) Discussion Break ESU Course on the treatment of localised and locally advanced prostate cancer Chair: Faculty: G. De Meerleer, Ghent (BE) Aims and objectives This course addresses the urological management of localized and locally advanced prostate cancer in all relevant aspects. The aim is to provide practical tips and tricks, taking into account the most recent developments in the field. Also, the management of recurrent disease will be reviewed and new developments in multimodal treatment will be critically assessed for their ability to improve cancer control European School of Urology: a unique possibility for urological education Introduction and aims Diagnosis, biopsy and staging of prostate cancer Planning the surgical procedure and estimating surgical risk Open nerve sparing radical prostatectomy for localized PCa (video) Robot assisted nerve sparing radical prostatectomy for localized PCa (video) Open and Robot assisted pelvic lymphadenectomy (video) Salvage Radical prostatectomy (video) Active surveillance

8 Discussion Break Round table on how to avoid and manage perioperative complications Vascular injury and bleeding Rectal injury Ureteral injury Prolonged urinary drainage Lymphocele Panel:,, Treatment of biochemical recurrence post surgery: Role of PET imaging Adjuvant and Salvage RT G. De Meerleer, Ghent (BE) Discussion and close o o o o o o STEPS (Session To Evaluate ProgresS) programme Closed programme: participation by invitation only Led by Prof. M. Brausi, Modena (IT) Prostate Cancer table: Chair: J Moul, Durham (US) Bladder Cancer table: Chair: S. Lerner, Houston (US) ESOU: P. Chlosta, Cracow (PL) ESOU: X. Xylinas, Paris (FR) Renal Cancer table: Chair: P. Mulders, Nijmegen (NL) ESOU: A. Volpe, Novara (IT) Testis Cancer table: Chair: D. Pfister, Cologne (DE) ESOU: M. Sedelaar, Nijmegen (NL) ESU Hands on training course in prostate MRI reading for urologists

9 Sunday, 20 January Renal cancer II: Locally advanced and metastatic Chairs: A. Bex, Amsterdam (NL) O. Rodriguez Faba, Barcelona (ES) Adjuvant therapy after nephrectomy for high risk RCC: should we recommend it? The urologist s perspective A. Bex, Amsterdam (NL) The oncologist s perspective A. Bamias, Athens (GR) Cytoreductive nephrectomy: What are the current recommendations? A. Mejean, Paris (FR) Revolution in first line treatment for mrcc: Where do we stand? P. Mulders, Nijmegen (NL) Discussion Panel discussion of clinical cases: Advanced and metastatic RCC Case presenter: O. Rodriguez Faba, Barcelona (ES) Break Panel: A. Bex, Amsterdam (NL) P. Mulders, Nijmegen (NL) M. Staehler, Munich (DE) Best of uro oncology 2018 Chairs: A. Breda, Barcelona (ES) P. Chlosta, Cracow (PL) Prostate cancer M. Sedelaar, Nijmegen (NL) Urothelial cancer M. Stanik, Brno (CZ) Renal cancer B. Akdogan, Ankara (TR) Testis and penile cancer B. Ayres, London (GB) Prostate cancer IV: Advanced and metastatic disease Chairs: N. Mottet, Saint Etienne (FR)

10 Oligo metastatic disease today Diagnostic and treatment J. Moul, Durham (US) Case presentation : How do I treat primary metastatic disease? Systemic therapy alone J. Bellmunt, Barcelona (ES) Surgery plus or minus radiotherapy Clinical case discussion J. Bellmunt, Barcelona (ES) How do I treat CRPC? A. Alcaraz, Barcelona (ES) Discussion Closing remarks M. Brausi, Modena (IT)